Cannara Biotech (CNSX:LOVE – Get Free Report) Director Donald John Olds acquired 25,000 shares of the stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average cost of $0.78 per share, with a total value of $19,400.00.
Cannara Biotech Stock Performance
Cannara Biotech Company Profile
Cannara Biotech Inc is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Featured Stories
- Five stocks we like better than Cannara Biotech
- Which Wall Street Analysts are the Most Accurate?
- The Great CPU Race: AMD and Intel Battle for Dominance
- How to Read Stock Charts for Beginners
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
